Clinical Trial Update: MRI Optimization Study in Stage III NSCLC

View source ↗

Summary

This document provides an update on an MRI optimization study for patients with stage III non-small cell lung cancer conducted by UMC Utrecht.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: UMC Utrecht | Conditions: Stage III Non-small Cell Lung Cancer | Status: UNKNOWN